Animalcare Group plc is a United Kingdom-based international veterinary pharmaceutical and services company. The Company develops and commercializes trusted prescription and over-the-counter pharmaceutical products, which improve animal health and wellbeing. These are developed in-house, acquired from other companies or in-licensed from its partners. The Company manage an international supply chain, including specialist veterinary wholesalers and distributors. It partners with companies to commercialize products across Europe. The Company operates in three categories within the veterinary market: Companion Animals, Equine and Production Animals. It focuses the Company’s people and product investment on three main therapy areas: pain management, dermatology and non-antibiotic anti-infectives. The Company’s product pipeline is Daxocox, which is a differentiated COX-2 inhibitor for the treatment of chronic pain in dogs.
CSRHub includes data on portfolio investment, investing, Compensation & Benefits, Sustainability, Chief Executives for Corporate Purpose, and Governance.